The Company
Sable Therapeutics is a biotechnology company that turns landmark scientific discoveries into beauty and wellness brands, each built on proprietary technology.
We sit at the intersection of healthcare and everyday care. Where the industry reaches backward to find science, Sable begins with it.
A science-first approach
Beauty has always sold on marketing and promise. We start with innovative, industry-changing discoveries, and build every brand around them.”
Daniel Chai, M.D. · Founder
The Approach
Founder
“We are bringing scientific integrity to an industry that often lacks it, helping people look and feel better in a way that is legitimate and authentic.”
Sable is the fourth company Daniel has built, and the one he is committed to for the long term. A physician by training, with a medical degree (M.D.) from Columbia University, he spent two decades as a biotech investor, building deep networks across biotech, pharma, and academia.
Before founding Sable he launched Turret Capital to incubate new companies. Sable represents the convergence of everything he has done: science, investing, and consumer-facing innovation.
His approach is one of curation. Rather than a single product, Sable is a house of brands, each one built on the best of what science makes possible.
The Vision
A global company that systematically finds the most promising science and turns it into brands people can live with every day.
Not one product but many brands, each built on a discovery of its own and launched only when the science is real. Transformative results, in place of perceived benefit.
A landmark invention
A patent‑pending ingredient that is a new generation‑3 polyamidoamine dendrimer, developed from a parent compound studied in preclinical research for its selective interaction with fat cells. It will power a new Sable brand of body care.
In an in vitro study by Genemarkers, Adicel reduced lipid accumulation in human fat cells by 23 percent over 24 hours.
Fat-cell volume reduced by up to 70 percent, reported for P‑G3 PAMAM in separate preclinical research.
Collaboration
Sable works with retailers, medical channels, and established brands to bring its discoveries to market. Let us discuss next steps.
